They have developed an F3 peptide-targeted liposomal strategy, targeting cell surface nucleolin, and 100% cell deaths were observed under the proposed link between the stem-like phenotype nucleolin expression in TNBC and F3 peptide-targeted synergistic drug combination, rendering 100% cancer cell death. This evidence concerns the gene NUCLEOLIN and cancer.